Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 8/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 9/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | FABP2 | P12104 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8468153 | 1.00 | PPARA (0.46) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL8667967 | 0.88 | CYP2C9 (0.48) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL8024659 | 0.85 | PPARG (0.41) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL28632413 | 0.83 | MEN1 (0.52) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL11513416 | 0.82 | SRC (0.50) | MEN1KMT2ACYP3A4MAPTPPARG | |
| SCHEMBL8468475 | 0.82 | KCNN4 (0.50) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL28644949 | 0.82 | KCNN4 (0.50) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL27580615 | 0.80 | PDK1 (0.42) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL247466 | 0.80 | PPARA (0.68) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL1538043 | 0.80 | PPARA (0.47) | PPARACYP2C19MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264177-A1 | METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2025-12-26 | — | — | WO | claimed |
| CN-119548414-A | Composition for lightening or whitening keratin materials | 莱雅公司 | 2025-03-04 | — | — | CN | claimed |
| US-20230020692-A1 | COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS | L'OREAL (FR) | 2023-01-19 | — | — | US | claimed |
| EP-4072510-A1 | COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS | L'OREAL (FR) | 2022-10-19 | — | — | EP | claimed |
| CN-115209862-A | Composition for lightening and/or whitening keratin materials | 莱雅公司 | 2022-10-18 | — | — | CN | claimed |
| CN-113518610-A | Composition for lightening or whitening keratin materials | 莱雅公司 | 2021-10-19 | — | — | CN | claimed |
| CN-113438938-A | Composition for lightening or whitening keratin materials | 莱雅公司 | 2021-09-24 | — | — | CN | claimed |
| CN-113226253-A | Composition for lightening or whitening keratin materials | 莱雅公司 | 2021-08-06 | — | — | CN | claimed |
| WO-2021114024-A1 | COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS | L'OREAL (FR) | 2021-06-17 | — | — | WO | claimed |
| CN-112409287-A | Oxazolecarboxamide intermediate and preparation method of oxazolecarboxamide | 宁夏蓝田农业开发有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-1337549-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2003-08-27 | — | — | EP | claimed |
| WO-2002053578-A2 | NOVEL APPLICATIONS FOR AN ANION EXCHANGE RESIN (EPM-8) | CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPQ (BR) | 2002-07-11 | — | — | WO | claimed |
| WO-2002050099-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | WO | claimed |
| US-20020082384-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | US | claimed |
| US-5886209-A | CATALYTIC ESTERIFICATION OF THE CHIRALIC CARBOXYLIC ACID IN PRESENCE OF A DISTILLABLE ACID CATALYST WITH AN ALCOHOL, WITHOUT PURIFICATION OF THE BOTTOMS PRODUCT, REPEATING THE ESTERIFICATION STEP | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-23 | — | — | US | claimed |
| US-5286789-A | Clear polystyrene functionalized with linking groups | APPLIED IMMUNE SCIENCES, INC. (US) | 1994-02-15 | — | — | US | claimed |
| EP-0352168-B1 | PROCESS FOR THE PURIFICATION OF D-HYDROXYPHENOXY PROPIONIC ACID | RHONE-POULENC CHIMIE (FR) | 1993-06-16 | — | — | EP | claimed |
| US-4981998-A | CRYSTALLIZATION, WASHING | RHONE-POULENC CHIMIE (FR) | 1991-01-01 | — | — | US | claimed |
| EP-0383613-A2 | Optically active lactate, derivatives thereof and processes of producing same | Tosoh Corporation (JP) | 1990-08-22 | — | — | EP | claimed |
| US-4767880-A | WITH ALKALI METAL ALCOHOLATE, PHENOLATE, HYDROXYPHENOXYPROPIONATE OR HYDROQUINONE SALT | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230020692-A1 | COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS | KRT18, TYR, MC1R | PPARA 305/4885CYP2C19 748/4885MEN1 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.